A detailed history of Payden & Rygel transactions in Pfizer Inc stock. As of the latest transaction made, Payden & Rygel holds 313,980 shares of PFE stock, worth $8.39 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
313,980
Previous 29,980 947.3%
Holding current value
$8.39 Million
Previous $839,000 983.08%
% of portfolio
0.7%
Previous 0.07%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $7.87 Million - $8.91 Million
284,000 Added 947.3%
313,980 $9.09 Million
Q1 2024

Oct 08, 2024

BUY
$25.89 - $29.73 $6.22 Million - $7.15 Million
240,400 Added 801.87%
270,380 $7.5 Million
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $634,959 - $824,742
24,300 Added 427.82%
29,980 $863,000
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $8.83 Million - $10.2 Million
-244,590 Reduced 97.73%
5,680 $208,000
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $9.6 Million - $12.5 Million
-243,720 Reduced 49.34%
250,270 $10.2 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $15 Million - $19.6 Million
-359,500 Reduced 42.12%
493,990 $25.3 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $910,208 - $1.11 Million
20,800 Added 2.5%
853,490 $37.3 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $5.9 Million - $6.99 Million
126,700 Added 17.95%
832,690 $43.7 Million
Q1 2022

Apr 13, 2022

BUY
$45.75 - $56.69 $9.59 Million - $11.9 Million
209,520 Added 42.2%
705,990 $36.5 Million
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $111,320 - $126,108
-3,100 Reduced 0.62%
496,470 $19.4 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $358,343 - $404,139
10,700 Added 2.19%
499,570 $18.1 Million
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $669,400 - $851,200
-20,000 Reduced 3.93%
488,870 $18 Million
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $701,675 - $823,225
22,100 Added 4.54%
508,870 $18.7 Million
Q1 2020

May 04, 2020

SELL
$27.03 - $38.62 $10 Million - $14.3 Million
-371,500 Reduced 43.28%
486,770 $15.9 Million
Q4 2019

Jan 31, 2020

SELL
$32.92 - $37.36 $121,804 - $138,232
-3,700 Reduced 0.43%
858,270 $33.6 Million
Q3 2019

Oct 30, 2019

SELL
$32.49 - $42.13 $711,531 - $922,647
-21,900 Reduced 2.48%
861,970 $31 Million
Q2 2019

Aug 06, 2019

BUY
$36.98 - $41.52 $2.8 Million - $3.14 Million
75,700 Added 9.37%
883,870 $38.3 Million
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $11,250 - $12,360
-300 Reduced 0.04%
808,170 $34.3 Million
Q4 2018

Jan 25, 2019

BUY
$38.47 - $43.86 $3.21 Million - $3.66 Million
83,500 Added 11.52%
808,470 $35.3 Million
Q3 2018

Nov 07, 2018

SELL
$34.47 - $41.81 $600,467 - $728,330
-17,420 Reduced 2.35%
724,970 $31.9 Million
Q2 2018

Aug 08, 2018

SELL
$32.98 - $35.16 $105,535 - $112,511
-3,200 Reduced 0.43%
742,390 $26.9 Million
Q1 2018

May 09, 2018

BUY
$31.91 - $37.02 $6.07 Million - $7.04 Million
190,300 Added 34.27%
745,590 $26.5 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $17.2 Million - $19 Million
555,290
555,290 $19.8 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Payden & Rygel Portfolio

Follow Payden & Rygel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel with notifications on news.